General Information
Fulvestrant is used in the treatment of hormone-sensitive advanced breast cancer in postmenopausal women.
About the API
Systematic name
7α-[9-[(4,4,5,5,5-Pentafluoropentyl)-sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17β-diol
Trade name(s)
Faslodex
Technology
High Potent
Molecular Formula
C32H47F5O3S
Therapeutic category
Oncology
Available formulations
Injectables
Injectables Long-Acting
Regulations
Canada DMF
CEP
EU DMF
Other
US DMF
Canada DMF
CEP
EU DMF
Other
US DMF